Skip to main content
logo
Alivus Life Sciences Limited (NSE:ALIVUS)
India flag India · Delayed Price · Currency is INR
1,158.00
+62.30 (5.69%)
Jul 31, 2026, 3:29 PM IST

Alivus Life Sciences Revenue

Alivus Life Sciences had revenue of 6.40B INR in the quarter ending June 30, 2026, with 6.41% growth. This brings the company's revenue in the last twelve months to 25.90B, up 7.93% year-over-year. In the fiscal year ending March 31, 2026, Alivus Life Sciences had annual revenue of 25.52B with 6.91% growth.

Revenue (ttm)
25.90B
Revenue Growth
+7.93%
P/S Ratio
5.50
Revenue / Employee
11.76M
Employees
2,203
Market Cap
142.38B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202625.52B1.65B6.91%
Mar 31, 202523.87B1.04B4.54%
Mar 31, 202422.83B1.22B5.64%
Mar 31, 202321.61B380.06M1.79%
Mar 31, 202221.23B2.38B12.63%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Piramal Pharma92.05B
Alembic Pharmaceuticals73.45B
Strides Pharma Science50.04B
Akums Drugs and Pharmaceuticals43.61B
NATCO Pharma40.78B
Wockhardt34.62B
Eris Lifesciences32.12B
Cohance Lifesciences22.69B
Revenue Rankings

Alivus Life Sciences News

More News